Investigative Site: #41 — Sedona, Arizona

Investigative Site: #41 is a clinical research site located in Sedona, Arizona, United States 86336.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site: #41 has participated in 1 clinical trials.

Therapeutic areas: KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer.

Sponsors: BIND Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sedona

Browse all research sites in Arizona · View every site in Sedona

• Northern Arizona Hematology & Oncology Associates
• Arizona Oncology Associates PC- NAHOA
• Northern AZ Hematology & Oncology Assoc
• Pfizer Investigational Site
• GSK Investigational Site
• Arizona Oncology Associates PC HAL
• Research Site
• Arizona Oncology Associates
• Northern Arizona Hematology & Oncology Associates, AOA
• USOR - Arizona Oncology Associates - Sedona
• Northern AZ Hematology Oncology Associates-AOA

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site: #41?

Investigative Site: #41 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site: #41 conducted?

Investigative Site: #41 has 1 clinical trials on record. Their work covers KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer.

Is Investigative Site: #41 accredited by Crixeo Clinical Trials?

Investigative Site: #41 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site: #41?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.